Vaica Medical Launches Capsuled™, a Novel Personally-Customized Medication Adherence Solution for Pharmaceutical Companies

TEL AVIV, Israel, Nov. 8, 2017 /PRNewswire/ -- Vaica announced the launch of Capsuled™, a personally-customized medication adherence solution, supporting any medication modality, for the use of pharmaceutical companies. The novel device is designed to create an accessible gateway to all patient-related digital information, along with timed encouragement messaging. Capsuled makes use of auditory and visual alerts to remind patients to take medication while integrating educational videos and closing the patient-caregiver-Patient Support Program (PSP) loop to enhance care outcomes. These features were especially designed in order to assist pharmaceutical companies to improve the patient journey and beyond the pill initiatives.

Vaica's technology will be immediately implemented in two extensive clinical studies conducted by one of the largest private hospital chains in Italy that chose to partner with Vaica and Telecare H24, a provider of telemedicine services. Patients with chronic diseases such as Cardiac Heart Disease (CHD), Diabetes Mellitus (DM) and Chronic Obstructive Pulmonary Disease (COPD) will participate in these studies that are aimed to improve medication adherence in chronically ill patient populations characterized by suboptimal medication adherence.  

For the purpose of these studies, Vaica developed a unique device designed to suit inhalers of different brands such as AstraZeneca's Eklira Genuair and Symbicort Turbohaler, as well as Boehringer Ingelheim's Spiriva and Respimat. Among other innovative features, this solution introduces a new capability of identifying the specific medication ID, and provides accurate knowledge of drug intake, time stamps and refills, as well as adherence data. 

"The Capsuled is a unique patient adherence product targeted specifically for the pharmaceutical industry. It offers an improved solution, based on our validated, FDA and CE approved technology," stated Tomer Gofer, CEO of Vaica. "Vaica's mission is to improve patients' lives through its customized medication adherence solutions. At the core of our technology is cloud-based software, enabling remote management of smart medication dispensers. This offers real time patient engagement, resulting in higher adherence levels, better patient outcomes and enhanced support.''

Vaica's medication adherence products are distributed worldwide and used by various healthcare organizations. The SimpleMed+, one of the Company's flagship products, based on the same technology as Capsuled, is utilized by hospitals such as McGill University Health Centre, The Children's Hospital of Philadelphia and Cincinnati Children's Hospital Medical Center, HMO's such as Israel's Maccabi Healthcare Services and Santa Helena Brazil, by Quantum Pharmaceuticals and more.

About TeleCare H24

TeleCare H24 provides telemedicine services to healthcare organizations and private customers, with the objective of enabling doctors, case managers and caregivers to remotely monitor and manage their patients. The all-round technological solution is coupled by the support of a 24/7 specialized call center and a territorial widespread network of healthcare professionals. www.telecareh24.it

About Vaica

Vaica provides medication adherence customized solutions in order to address the wide spread phenomena of medication non-compliance and improve the life quality of chronically-ill patients. For additional information, please visit www.vaica.com

Company Contact  
Noa Lapidot  
Business Development Manager  
Vaica 
+972-52-332-4466  
[email protected]

Media Contact  
Tsipi Haitovsky  
Global Media Liaison   
Vaica   
+972-52-598-9892  
[email protected]   

SOURCE Vaica Medical

Related Links

http://www.vaica.com